CVR number 37634557
Industry 87.2010 Residential care activities for mental retardation, mental health and substance abuse

Socialpsykiatriske Botilbud Vedelsbo ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.2% 5.2% 5.8% 7.9% 5.5%  
Credit score (0-100)  48 41 39 30 41  
Credit rating  BBB BBB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  4,273 4,745 5,409 5,365 5,649  
EBITDA  489 491 342 368 314  
EBIT  419 400 222 275 232  
Pre-tax profit (PTP)  365.5 413.7 231.4 313.6 289.0  
Net earnings  284.3 323.5 180.7 242.9 224.5  
Pre-tax profit without non-rec. items  365 414 231 314 289  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  408 682 567 253 515  
Shareholders equity total  1,486 610 540 783 1,008  
Interest-bearing liabilities  0.0 24.6 438 0.0 0.0  
Balance sheet total (assets)  2,996 1,894 1,647 2,243 2,262  
Net Debt  -253 -6.5 390 -731 -464  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,273 4,745 5,409 5,365 5,649  
Gross profit growth  7.9% 11.0% 14.0% -0.8% 5.3%  
Employees  7 8 10 9 9  
Employee growth %  -12.5% 14.3% 25.0% -10.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,996 1,894 1,647 2,243 2,262  
Balance sheet change%  33.4% -36.8% -13.0% 36.2% 0.8%  
Added value  489.4 490.9 341.7 394.6 314.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -140 183 -234 -406 179  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  9.8% 8.4% 4.1% 5.1% 4.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  16.6% 17.9% 13.6% 16.4% 12.9%  
ROI %  28.2% 35.5% 26.9% 35.7% 32.5%  
ROE %  20.3% 30.9% 31.4% 36.7% 25.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  57.9% 42.7% 33.2% 49.5% 62.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -51.7% -1.3% 114.2% -198.6% -147.6%  
Gearing %  0.0% 4.0% 81.2% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 190.2% 3.7% 2.1% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.5 1.6 0.8 2.2 2.6  
Current Ratio  1.7 0.9 0.9 1.3 1.3  
Cash and cash equivalent  253.0 31.1 48.3 730.9 463.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  953.4 -72.2 -60.5 389.7 350.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  70 61 34 44 35  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  70 61 34 41 35  
EBIT / employee  60 50 22 31 26  
Net earnings / employee  41 40 18 27 25